Related references
Note: Only part of the references are listed.Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel disease
Masayoshi Ohkuro et al.
NATURE COMMUNICATIONS (2018)
Synthesis and Evaluation of New Bifunctional Chelators with Phosphonic Acid Arms for Gallium-68 Based PET Imaging in Melanoma
Yongkang Gai et al.
BIOCONJUGATE CHEMISTRY (2018)
DS-70, a novel and potent alpha(4) integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs
Samantha Deianira Dattoli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
alpha(4)beta(7) integrin inhibitors: a patent review
Hao Li et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Natalizumab for induction of remission in Crohn's disease
Seana M. L. Nelson et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Age-related tumor growth in mice is related to integrin alpha 4 in CD8(+) T cells
Juhyun Oh et al.
JCI INSIGHT (2018)
The α4β1 Homing Pathway Is Essential for Ileal Homing of Crohn's Disease Effector T Cells In Vivo
Sebastian Zundler et al.
INFLAMMATORY BOWEL DISEASES (2017)
Natalizumab in Multiple Sclerosis: Long-Term Management
Marinella Clerico et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology
Afsaneh Shirani et al.
JOURNAL OF IMMUNOLOGY (2017)
Anti-Adhesion Therapies in inflammatory Bowel Disease-Molecular and Clinical Aspects
Sebastian Zundler et al.
FRONTIERS IN IMMUNOLOGY (2017)
Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators
Alessandra Tolomelli et al.
CANCERS (2017)
Multiple Sclerosis: Immunopathology and Treatment Update
Narges Dargahi et al.
BRAIN SCIENCES (2017)
Facile synthesis and 18F-radiolabeling of α4β1-specific LLP2A-aryltrifluoroborate peptidomimetic conjugates
Daniel Walker et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Enhanced in utero allogeneic engraftment in mice after mobilizing fetal HSCs by α4β1/7 inhibition
Aimee G. Kim et al.
BLOOD (2016)
New β-Lactam Derivatives Modulate Cell Adhesion and Signaling Mediated by RGD-Binding and Leukocyte Integrins
Monica Baiula et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Integrin-based therapeutics: biological basis, clinical use and new drugs
Klaus Ley et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Therapeutic targeting and rapid mobilization of endosteal HSC using a small molecule integrin antagonist
Benjamin Cao et al.
NATURE COMMUNICATIONS (2016)
5-Aminomethyloxazolidine-2,4-dione Hybrid α/β-Dipeptide Scaffolds as Inductors of Constrained Conformations: Applications to the Synthesis of Integrin Antagonists
Rossella De Marco et al.
BIOPOLYMERS (2015)
Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis
Martin Schlesinger et al.
CANCER AND METASTASIS REVIEWS (2015)
Leukocyte integrins: Role in leukocyte recruitment and as therapeutic targets in inflammatory disease
Ioannis Mitroulis et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Dehydro-β-proline Containing α4β1 Integrin Antagonists: Stereochemical Recognition in Ligand-Receptor Interplay
Alessandra Tolomelli et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Asthma: definitions and pathophysiology
James W. Mims
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2015)
Improvement of Outcome Measures of Dry Eye by a Novel Integrin Antagonist in the Murine Desiccating Stress Model
Achim H. Krauss et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Bortezomib is a rapid mobilizer of hematopoietic stem cells in mice via modulation of the VCAM-1/VLA-4 axis
Armin Ghobadi et al.
BLOOD (2014)
Phase II drugs under investigation for allergic conjunctivitis
Monica Baiula et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Multifunctional Activity of a Small Tellurium Redox Immunomodulator Compound, AS101, on Dextran Sodium Sulfate-induced Murine Colitis
Gilad Halpert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Design, synthesis and binding properties of a fluorescent α9β1/α4β1 integrin antagonist and its application as an in vivo probe for bone marrow haemopoietic stem cells
Benjamin Cao et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid
Masaki Setoguchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Synthesis and evaluation of 4,5-dihydro-5-methylisoxazolin-5-carboxamide derivatives as VLA-4 antagonists
Ajay Soni et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonists
Jefferson W. Tilley et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Orally available and efficacious α4β1/α4β7 integrin inhibitors
Ying-zi Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
PEG conjugates of potent α4 integrin inhibitors, maintaining sustained levels and bioactivity in vivo, following subcutaneous administration
Jenifer L. Smith et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Arylsulfonamide pyrimidines as VLA-4 antagonists
Ying-zi Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Integrin modulators: a patent review
Tobias G. Kapp et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Small Molecule Agonist of Very Late Antigen-4 (VLA-4) Integrin Induces Progenitor Cell Adhesion
Peter Vanderslice et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Oral treatment with a novel small molecule alpha 4 integrin antagonist, AJM300, prevents the development of experimental colitis in mice
Toshihiko Sugiura et al.
Journal of Crohns & Colitis (2013)
Integrin Regulation during Leukocyte Recruitment
Jan Herter et al.
JOURNAL OF IMMUNOLOGY (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Identification of trans-4-[1-[[ 7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist
Masaki Setoguchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
LDV peptidomimetics equipped with biotinylated spacer-arms: Synthesis and biological evaluation on CCRF-CEM cell line
Estelle Gerard et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Diaryl urea LDV peptidomimetics as α4β1 integrin antagonists: synthesis, adhesion inhibition and toxicity evaluation on CCRF-CEM cell line
Estelle Gerard et al.
MEDCHEMCOMM (2012)
Modeling the molecular basis for α4β1 integrin antagonism
Oliver E. Hutt et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Discovery of a potent, orally bioavailable pyrimidine VLA-4 antagonist effective in a sheep asthma model
Christopher M. Semko et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Discovery of Potential Integrin VLA-4 Antagonists Using Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies
Sundarapandian Thangapandian et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
Potent in vivo suppression of inflammation by selectively targeting the high affinity conformation of integrin alpha 4 beta 1
Peter Vanderslice et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Antiangiogenic Effect of Dual/Selective α5β1/αvβ3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics
Luca Gentilucci et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Analysis of alpha(4)beta(1) Integrin Specific Antagonists Binding Modes: Structural Insights by Molecular Docking, Molecular Dynamics and Linear Interaction Energy Method for Free Energy Calculations
Joao Herminio Martins da Silva et al.
JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY (2010)
A small molecule inhibitor of α4 integrin-dependent cell migration
Jongkook Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(L)- prolyl}-4-[(3′,5′-dichloro-isonicotinoyl) amino]-(L)-phenylalanine (MK-0617), a highly potent and orally active VLA-4 antagonist
Shankar Venkatraman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells
Pablo Ramirez et al.
BLOOD (2009)
Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with α9β1 and α4β1 integrins
Jochen Grassinger et al.
BLOOD (2009)
Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 Antagonist
Fumihito Muro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
111In-LLP2A-DOTA Polyethylene Glycol-Targeting α4β1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies
Sally J. DeNardo et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
K. Noborio-Hatano et al.
ONCOGENE (2009)
Modulation of Integrin α4β1 (VLA-4) in Dry Eye Disease
Tatiana Ecoiffier et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Contribution of α4β1 integrin to the antiallergic effect of levocabastine
Ahmed R. Qasem et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Impact of dry eye syndrome on vision-related quality of life
Biljana Miljanovic et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
LFA-I and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue
Huaxin Duan et al.
THROMBOSIS AND HAEMOSTASIS (2006)
Combinatorial chemistry identifies high-affinity peptidomimetics against α4β1 integrin for in vivo tumor imaging
Li Peng et al.
NATURE CHEMICAL BIOLOGY (2006)
A small molecule α4β1 antagonist prevents development of murine Lyme arthritis without affecting protective immunity
J Gläsner et al.
JOURNAL OF IMMUNOLOGY (2005)
Different embryo-fetal toxicity effects for three VLA-4 antagonists
F Crofts et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2004)
Adhesion mechanisms regulating the migration of monocytes
BA Imhof et al.
NATURE REVIEWS IMMUNOLOGY (2004)
The identification and optimization of orally efficacious, small molecule VLA-4 antagonists
DM Huryn et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Identification of potent and novel α4β1 antagonists using in silico screening
J Singh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
VLA-4 antagonists
JW Tilley
EXPERT OPINION ON THERAPEUTIC PATENTS (2002)
Comparative assessment of the ligand and metal ion binding properties of integrins α9β1 and α4β1
RB Pepinsky et al.
BIOCHEMISTRY (2002)
Alpha 4 integrin antagonists
DY Jackson
CURRENT PHARMACEUTICAL DESIGN (2002)
A 3D structure model of integrin alpha 4 beta 1 complex: I. Construction of a homology model of beta 1 and ligand binding analysis
TJ You et al.
BIOPHYSICAL JOURNAL (2002)
The discovery of sulfonylated dipeptides as potent VLA-4 antagonists
WK Hagmann et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Chemoattractants induce a rapid and transient upregulation of monocyte α4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest:: An early step in the process of emigration
JR Chan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
beta 7 integrins contribute to demyelinating disease of the central nervous system
JR Kanwar et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Share Paper
